• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.

作者信息

Janne d'Othée Bertrand, Sofocleous Constantinos T, Hanna Nader, Lewandowski Robert J, Soulen Michael C, Vauthey Jean-Nicolas, Cohen Steven J, Venook Alan P, Johnson Matthew S, Kennedy Andrew S, Murthy Ravi, Geschwind Jean-Francois, Kee Stephen T

机构信息

Department of Diagnostic Radiology and Nuclear Medicine, Division of Vascular and Interventional Radiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.

出版信息

J Vasc Interv Radiol. 2012 Feb;23(2):153-63. doi: 10.1016/j.jvir.2011.12.003.

DOI:10.1016/j.jvir.2011.12.003
PMID:22264550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4352314/
Abstract
摘要

相似文献

1
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.转移性结直肠癌管理研究议程的制定：多学科研究共识小组会议纪要
J Vasc Interv Radiol. 2012 Feb;23(2):153-63. doi: 10.1016/j.jvir.2011.12.003.
2
Development of a research agenda for evaluation of interventional therapies for chronic cerebrospinal venous insufficiency: proceedings from a multidisciplinary research consensus panel.慢性脑脊髓静脉功能不全介入治疗评估研究议程的制定：多学科研究共识小组会议纪要
J Vasc Interv Radiol. 2011 May;22(5):587-93. doi: 10.1016/j.jvir.2011.03.007.
3
Development of a research agenda for skeletal intervention: proceedings of a multidisciplinary consensus panel.骨骼干预研究议程的制定：多学科共识小组会议记录
Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):678-86. doi: 10.1007/s00270-008-9305-9. Epub 2008 Mar 21.
4
Development of a research agenda for uterine artery embolization: proceedings from a multidisciplinary research consensus panel.子宫动脉栓塞术研究议程的制定：多学科研究共识小组会议纪要
J Vasc Interv Radiol. 2006 Dec;17(12):1871-9. doi: 10.1097/01.RVI.0000251151.01365.c1.
5
[When "interventional" (neuroradiology) replaces neurosurgery].当“介入性（神经放射学）”取代神经外科手术时。
Rev Infirm. 1998 Sep(41):39-42.
6
Development of a research agenda for skeletal intervention: proceedings from a multidisciplinary consensus panel.
J Vasc Interv Radiol. 2008 May;19(5):631-8. doi: 10.1016/j.jvir.2008.01.021. Epub 2008 Mar 24.
7
[Interventional procedures in the area of the external carotid artery].[颈外动脉区域的介入手术]
Acta Stomatol Belg. 1989 Dec;86(4):275-88.
8
Delayed, life-threatening lower gastrointestinal hemorrhage in an infant after serial transverse enteroplasty: treatment with transcatheter n-butyl-2-cyanoacrylate embolization.系列横断肠成形术后婴儿发生的延迟性、危及生命的下消化道出血：经导管注射正丁基-2-氰基丙烯酸酯栓塞治疗
Pediatr Radiol. 2009 Oct;39(10):1098-101. doi: 10.1007/s00247-009-1328-0. Epub 2009 Jul 7.
9
[Methods of roentgen-endovascular interventions on the adrenal glands].[肾上腺的X线血管内介入治疗方法]
Vestn Khir Im I I Grek. 2004;163(2):116-8.
10
Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?社论：转移性结直肠癌的放射性栓塞治疗：终于走向成熟了吗？
Curr Opin Oncol. 2021 Jul 1;33(4):351-352. doi: 10.1097/CCO.0000000000000749.

引用本文的文献

1
Oncologic Outcomes after Percutaneous Ablation for Colorectal Liver Metastases: An Updated Comprehensive Review.经皮消融治疗结直肠癌肝转移瘤的肿瘤学结局：最新全面综述。
Medicina (Kaunas). 2024 Sep 20;60(9):1536. doi: 10.3390/medicina60091536.
2
Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer.转移性结直肠癌肝靶向局部治疗前后的影像考量
Diagnostics (Basel). 2024 Apr 5;14(7):772. doi: 10.3390/diagnostics14070772.
3
Optimizing Loco Regional Management of Oligometastatic Colorectal Cancer: Technical Aspects and Biomarkers, Two Sides of the Same Coin.优化寡转移性结直肠癌的局部区域管理：技术层面与生物标志物，同一硬币的两面
Cancers (Basel). 2021 May 26;13(11):2617. doi: 10.3390/cancers13112617.
4
Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.使用载有90Y的树脂微球进行挽救性放射性栓塞术后结直肠癌肝转移反应的替代影像生物标志物
AJR Am J Roentgenol. 2016 Sep;207(3):661-70. doi: 10.2214/AJR.15.15202. Epub 2016 Jul 6.
5
Metabolic tumor volume and total lesion glycolysis on FDG-PET/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: A comparison with SUVmax, SUVpeak, and RECIST 1.0.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）上的代谢肿瘤体积和总病变糖酵解可预测结直肠癌肝转移经（90）Y放射性栓塞后的总生存期：与SUVmax、SUVpeak和实体瘤疗效评价标准（RECIST）1.0的比较
Eur J Radiol. 2016 Jun;85(6):1224-31. doi: 10.1016/j.ejrad.2016.03.029. Epub 2016 Mar 31.
6
Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes.放射性栓塞作为经大量治疗的结直肠癌肝转移患者的挽救性治疗：影响预后的因素
Clin Colorectal Cancer. 2015 Dec;14(4):296-305. doi: 10.1016/j.clcc.2015.06.003. Epub 2015 Jun 27.
7
Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver.动脉内治疗后的早期生存预测：对结直肠癌肝转移灶进行经动脉化疗栓塞术（TACE）或放射性栓塞术后肿瘤反应的三维定量磁共振成像评估
Eur Radiol. 2015 Jul;25(7):1993-2003. doi: 10.1007/s00330-015-3595-5. Epub 2015 Jan 31.
8
Radiofrequency ablation: effect of tumor- and organ-specific pharmacologic modulation of arterial and portal venous blood flow on coagulation diameter in an N1-S1 tumor model.射频消融：肿瘤和器官特异性药物调节动脉和门静脉血流对 N1-S1 肿瘤模型中凝固直径的影响。
J Vasc Interv Radiol. 2012 Jun;23(6):826-32. doi: 10.1016/j.jvir.2012.02.010. Epub 2012 Apr 14.

本文引用的文献

1
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer.肝切除术后转移性结直肠癌辅助全身化疗与肝动脉灌注化疗的比较。
Ann Surg. 2011 Dec;254(6):851-6. doi: 10.1097/SLA.0b013e31822f4f88.
2
Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer.溶热敏脂质体多柔比星：辅助提高肝癌射频消融的治愈率。
Future Oncol. 2011 Aug;7(8):937-45. doi: 10.2217/fon.11.73.
3
Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases.比较联合放射性栓塞和最佳支持治疗与单纯最佳支持治疗对化疗抵抗的肝优势结直肠癌转移的配对比较。
Cardiovasc Intervent Radiol. 2012 Oct;35(5):1066-73. doi: 10.1007/s00270-011-0234-7. Epub 2011 Jul 29.
4
Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer.放射性栓塞联合全身化疗作为结直肠癌肝转移的一线治疗。
J Vasc Interv Radiol. 2011 Jun;22(6):780-6. doi: 10.1016/j.jvir.2011.02.023. Epub 2011 Apr 22.
5
CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.CT 引导下射频消融作为肝切除术后结直肠癌肝转移的挽救性治疗。
J Vasc Interv Radiol. 2011 Jun;22(6):755-61. doi: 10.1016/j.jvir.2011.01.451. Epub 2011 Apr 22.
6
Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer.随机Ⅱ期试验：辅助性肝动脉灌注化疗和全身化疗联合或不联合贝伐珠单抗治疗结直肠癌术后肝转移患者。
J Clin Oncol. 2011 Mar 1;29(7):884-9. doi: 10.1200/JCO.2010.32.5977. Epub 2010 Dec 28.
7
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?围手术期化疗对单发、异时性结直肠癌肝转移是否有效？
Ann Surg. 2010 Nov;252(5):774-87. doi: 10.1097/SLA.0b013e3181fcf3e3.
8
Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol.顺铂、多柔比星、丝裂霉素 C、碘油、聚乙烯醇栓塞治疗结直肠癌肝转移
Cancer. 2011 Jan 15;117(2):343-52. doi: 10.1002/cncr.25387. Epub 2010 Sep 9.
9
Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres.钇-90 微球放射性栓塞治疗肝转移瘤挽救性患者人群的生存结果。
J Vasc Interv Radiol. 2010 Oct;21(10):1521-6. doi: 10.1016/j.jvir.2010.06.018. Epub 2010 Sep 1.
10
Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.经全身化疗耐药的不可切除结直肠癌肝转移瘤患者行肝动脉内载药微球（DEBIRI）注射伊立替康治疗：多中心研究结果。
Ann Surg Oncol. 2011 Jan;18(1):192-8. doi: 10.1245/s10434-010-1288-5. Epub 2010 Aug 26.